The FSIGT was added to the study protocol after a report indicated first-phase insulin release to glucose may be impaired in older carriers of ABCA1 mutations (1).
The FSIGT parameters for intravenous glucose tolerance (K g ), acute insulin response to the injection of glucose (AIR glu ), insulin sensitivity (S I ), glucose effectiveness (S G ), and disposition index (D I ) were derived from Bergman's minimal model using MINMOD Millennium software (3) as previously described (4).
A subset of study subjects (1 ABCA1 mutation homozygote, 5 ABCA1 mutation heterozygotes and their matched control subjects, and all 9 isolated low HDL cholesterol subjects and their matched control subjects) underwent the FSIGT test. While the FSIGT test was only conducted in one ABCA1 homozygous subject, the outcome parameters were comparable to those of control subjects (Supplemental Table) . No differences were observed in intravenous glucose tolerance, K g , first-phase insulin release, AIR glu , insulin-dependent glucose disposal, S I , insulin-independent glucose disposal, S G , or disposition index, D I , between ABCA1 heterozygous subjects and their controls (Supplemental Table; Supplemental Figure) . By contrast, in subjects with isolated low HDL-C, while K g and S G were not different, AIR glu was greater and S I was less (P < 0.05 for both), and so the resulting D I was not different than in controls (Supplemental Table; Supplemental Figure) .
Concordant to the results obtained from the GPA test, in the ABCA1 heterozygous subjects first-phase insulin release to glucose (AIR glu ) was normal, as was insulin sensitivity (S I ) derived from the minimal model, while in the isolated low HDL-C subjects AIR glu was increased with a corresponding decrease in S I . As a result, the disposition index (D I ) was not different between both the ABCA1 heterozygous or isolated low HDL-C group and their respective control groups, confirming the normal D I reported with the GPA test. Of note, the normal measures of first-phase insulin release under fasting conditions observed in ABCA1 heterozygous subjects are appropriate for subjects with the normal insulin sensitivity, as reflected in the normal disposition indices. These results further support that loss-offunction in ABCA1 per se does not negatively affect the ability of the β-cell to secrete insulin in response to glucose, and confirm in the low HDL-C group that the increased insulin secretion reflects normal β-cell compensation for the decrease in insulin sensitivity. Data are means ± SE. ABCA1, ATP-binding cassette transporter subfamily A member 1; HDL-C, high density lipoprotein cholesterol; K g , glucose disappearance rate; AIR glu , acute insulin response to glucose; S I , insulin sensitivity; S G , glucose effectiveness; D I , disposition index equal to AIR glu x S I . * P < 0.05 cases vs. matched controls.
Supplementary Figure. Plasma glucose (A and B)
and insulin (C and D) levels during the 0.3 g/kg frequently-sampled intravenous glucose tolerance test in ABCA1 heterozygous (n = 5) and matched normal control (n = 5) subjects (A and C), and in isolated low HDL cholesterol (n = 9) and matched normal control (n = 9) subjects (B and D). First-phase insulin release (AIR glu ) was greater in the isolated low HDL-C compared to normal control subjects (P < 0.05), and was associated with a proportionate decrease in minimal model derived insulin sensitivity (S I ; P < 0.05) such that the disposition index (D I ) was unchanged. 
